Literature DB >> 8224071

Alterations in striatal glial fibrillary acidic protein expression in response to 6-hydroxydopamine-induced denervation.

J G Sheng1, S Shirabe, N Nishiyama, J P Schwartz.   

Abstract

Following injection of 6-hydroxydopamine (6-OHDA) into one side of the substantia nigra, immunohistochemical studies showed that the number of glial fibrillary acidic protein-positive [GFAP(+)] astrocytes in the striatum was significantly increased 1 day later and reached a maximum value, with intense immunoreactivity, 4 days after 6-OHDA injection. The number of GFAP(+) cells then gradually declined but was still 1.7 times the control value by 28 days postlesion. GFAP content, determined by immunoblot, and GFAP messenger RNA (mRNA) both reached maximal increases in the striatum 7 days after lesion: the mRNA returned to control values by 28 days, whereas GFAP content remained significantly elevated. Although the increases were all larger on the lesioned side, there were also significant changes on the contralateral side, as well as following saline injection. These results support the hypothesis that products released from damaged neurons are responsible for the induction of reactive gliosis, but cannot distinguish between effects mediated directly on the astrocytes or indirectly via other cells such as the microglia.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8224071     DOI: 10.1007/bf00227138

Source DB:  PubMed          Journal:  Exp Brain Res        ISSN: 0014-4819            Impact factor:   1.972


  36 in total

1.  Inhibition of neurite outgrowth on astroglial scars in vitro.

Authors:  J S Rudge; J Silver
Journal:  J Neurosci       Date:  1990-11       Impact factor: 6.167

2.  Reduction of striatal dopaminergic neurotransmission elevates striatal proenkephalin mRNA.

Authors:  J A Angulo; L G Davis; B A Burkhart; G R Christoph
Journal:  Eur J Pharmacol       Date:  1986-11-04       Impact factor: 4.432

3.  Immunohistochemical studies on the proliferation of reactive astrocytes and the expression of cytoskeletal proteins following brain injury in rats.

Authors:  Y Takamiya; S Kohsaka; S Toya; M Otani; Y Tsukada
Journal:  Brain Res       Date:  1988-02-01       Impact factor: 3.252

Review 4.  Regulation of glial fibrillary acidic protein (GFAP) expression in CNS development and in pathological states.

Authors:  F C Chiu; J E Goldman
Journal:  J Neuroimmunol       Date:  1985-06       Impact factor: 3.478

5.  The neurotoxicant MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) increases glial fibrillary acidic protein and decreases dopamine levels of the mouse striatum: evidence for glial response to injury.

Authors:  J F Reinhard; D B Miller; J P O'Callaghan
Journal:  Neurosci Lett       Date:  1988-12-19       Impact factor: 3.046

6.  Hormones and growth factors induce the synthesis of glial fibrillary acidic protein in rat brain astrocytes.

Authors:  R S Morrison; J De Vellis; Y L Lee; R A Bradshaw; L F Eng
Journal:  J Neurosci Res       Date:  1985       Impact factor: 4.164

7.  Evidence for a role of neosynthetized putrescine in the increase of glial fibrillary acidic protein immunoreactivity induced by a mechanical lesion in the rat brain.

Authors:  I Zini; M Zoli; R Grimaldi; E M Pich; G Biagini; K Fuxe; L F Agnati
Journal:  Neurosci Lett       Date:  1990-11-27       Impact factor: 3.046

8.  Effects of mycophenolic acid on detection of glial filaments in human and rat astrocytoma cultures.

Authors:  R H Lipsky; S J Silverman
Journal:  Cancer Res       Date:  1987-09-15       Impact factor: 12.701

9.  Identification of a human glial fibrillary acidic protein cDNA: a tool for the molecular analysis of reactive gliosis in the mammalian central nervous system.

Authors:  P Rataboul; N Faucon Biguet; P Vernier; F De Vitry; S Boularand; A Privat; J Mallet
Journal:  J Neurosci Res       Date:  1988       Impact factor: 4.164

10.  Immunohistochemistry of glial fibrillary acidic protein, vimentin and S-100 protein for study of astrocytes in hippocampus of rat.

Authors:  R Schmidt-Kastner; J Szymas
Journal:  J Chem Neuroanat       Date:  1990 May-Jun       Impact factor: 3.052

View more
  10 in total

Review 1.  Glial cell response: A pathogenic factor in Parkinson's disease.

Authors:  Du Chu Wu; Kim Tieu; Oren Cohen; Dong-Kug Choi; Miquel Vila; Vernice Jackson-Lewis; Peter Teismann; Serge Przedborski
Journal:  J Neurovirol       Date:  2002-12       Impact factor: 2.643

2.  Transgene expression in the striatum following intracerebral injections of DNA nanoparticles encoding for human glial cell line-derived neurotrophic factor.

Authors:  A M Fletcher; T H Kowalczyk; L Padegimas; M J Cooper; D M Yurek
Journal:  Neuroscience       Date:  2011-08-04       Impact factor: 3.590

3.  Astrocyte-neuron interactions in neurological disorders.

Authors:  G Ricci; L Volpi; L Pasquali; L Petrozzi; G Siciliano
Journal:  J Biol Phys       Date:  2009-05-14       Impact factor: 1.365

Review 4.  Modulation of microglial pro-inflammatory and neurotoxic activity for the treatment of Parkinson's disease.

Authors:  Bin Liu
Journal:  AAPS J       Date:  2006-09-29       Impact factor: 4.009

5.  Exercise improves motor deficits and alters striatal GFAP expression in a 6-OHDA-induced rat model of Parkinson's disease.

Authors:  Márcio Ferreira Dutra; Mariane Jaeger; Jocemar Ilha; Pedro Ivo Kalil-Gaspar; Simone Marcuzzo; Matilde Achaval
Journal:  Neurol Sci       Date:  2012-01-10       Impact factor: 3.307

6.  Increased neuronal beta-amyloid precursor protein expression in human temporal lobe epilepsy: association with interleukin-1 alpha immunoreactivity.

Authors:  J G Sheng; F A Boop; R E Mrak; W S Griffin
Journal:  J Neurochem       Date:  1994-11       Impact factor: 5.372

7.  The role of alpha-synuclein in brain lipid metabolism: a downstream impact on brain inflammatory response.

Authors:  Mikhail Y Golovko; Gwendolyn Barceló-Coblijn; Paula I Castagnet; Susan Austin; Colin K Combs; Eric J Murphy
Journal:  Mol Cell Biochem       Date:  2008-12-31       Impact factor: 3.396

8.  Dementia in Parkinson's Disease Correlates with α-Synuclein Pathology but Not with Cortical Astrogliosis.

Authors:  Simone A van den Berge; Josta T Kevenaar; Jacqueline A Sluijs; Elly M Hol
Journal:  Parkinsons Dis       Date:  2012-04-22

9.  Neuroinflammation in early, late and recovery stages in a progressive parkinsonism model in rats.

Authors:  Debora M G Cunha; Marcela Becegato; Ywlliane S R Meurer; Alvaro C Lima; Narriman Gonçalves; Vinícius S Bioni; Sheila A Engi; Paula C Bianchi; Fabio C Cruz; Jose R Santos; Regina H Silva
Journal:  Front Neurosci       Date:  2022-08-26       Impact factor: 5.152

Review 10.  Elusive roles for reactive astrocytes in neurodegenerative diseases.

Authors:  Lucile Ben Haim; Maria-Angeles Carrillo-de Sauvage; Kelly Ceyzériat; Carole Escartin
Journal:  Front Cell Neurosci       Date:  2015-08-03       Impact factor: 5.505

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.